Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan vs RAPAE01 Triple Therapy for H. pylori Eradication
NCT04128917Phase 3Completed
- Sponsor
- HK inno.N Corporation
- Start
- Jan 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in Helicobacter pylori infection, sponsored by HK inno.N Corporation. Started Jan 2020; status: completed.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04128917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04128917.